Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1971-7-13
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0012-0219
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
4
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
463-5
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:4930772-Azocines,
pubmed-meshheading:4930772-Clinical Trials as Topic,
pubmed-meshheading:4930772-Humans,
pubmed-meshheading:4930772-Placebos,
pubmed-meshheading:4930772-Pyridines,
pubmed-meshheading:4930772-Questionnaires,
pubmed-meshheading:4930772-Smoking,
pubmed-meshheading:4930772-Substance-Related Disorders
|
pubmed:year |
1971
|
pubmed:articleTitle |
[Cytisine (Tabex) as a pharmaceutical aid in stopping smoking].
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|